DocGo Inc. (NASDAQ:DCGO – Get Rating)’s stock price hit a new 52-week low during mid-day trading on Thursday after Canaccord Genuity Group lowered their price target on the stock from $13.00 to $10.00. The stock traded as low as $5.18 and last traded at $5.23, with a volume of 1882942 shares changing hands. The stock had previously closed at $6.35.
Other analysts also recently issued research reports about the stock. Needham & Company LLC reissued a “buy” rating and set a $14.00 price target on shares of DocGo in a research report on Wednesday, March 16th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of DocGo in a research report on Tuesday, April 19th. They set a “buy” rating and a $11.00 price target for the company. Zacks Investment Research raised shares of DocGo from a “hold” rating to a “buy” rating and set a $9.25 price target for the company in a research report on Thursday, March 17th. Finally, Stifel Nicolaus initiated coverage on shares of DocGo in a research report on Wednesday, January 19th. They set a “buy” rating and a $14.00 price target for the company. Seven equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, DocGo has a consensus rating of “Buy” and a consensus target price of $13.41.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Evoke Wealth LLC bought a new position in DocGo during the fourth quarter worth $47,000. Lazard Asset Management LLC bought a new position in DocGo during the fourth quarter worth $50,000. Penserra Capital Management LLC bought a new position in DocGo during the fourth quarter worth $50,000. Wealthstream Advisors Inc. bought a new position in DocGo during the fourth quarter worth $102,000. Finally, Victory Capital Management Inc. bought a new position in DocGo during the fourth quarter worth $106,000. Hedge funds and other institutional investors own 16.03% of the company’s stock.
The business’s 50 day simple moving average is $7.78.
DocGo Company Profile (NASDAQ:DCGO)
DocGo, Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company’s transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider DocGo, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and DocGo wasn’t on the list.
While DocGo currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.